Home > Analytics > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Intrinsic Value | Fundamental Analysis

BOM : 500126     NSE : PGHL    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Sep 30,2022
Price(EOD): ₹ 4,090.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 6,790.06 Cr
Value of ₹ 1 Lac invested in PROCTER & GAMBLE HEALTH
on Oct 03,2017 (price: ₹ 1,036.00)

₹ 1 L

₹ 3.95 L

1W : 2.1% 1M : -4% 1Y : -25.6%
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
PROCTER & GAMBLE HEALTH 2.1% -4% -25.6%
SUN PHARMACEUTICAL INDUSTRIES 5.8% 8.9% 19.4%
DIVIS LABORATORIES 0.4% 2.4% -27.6%
DR REDDYS LABORATORIES 4.9% 3.1% -9.1%
CIPLA 4.7% 9% 14.9%
GLAND PHARMA 1.5% -16.4% -43.2%
PIRAMAL ENTERPRISES -2.9% -16% -68.6%
CADILA HEALTHCARE 8.6% 3.8% -29.6%
TORRENT PHARMACEUTICALS 3% 1.5% -0.4%

FUNDAMENTAL ANALYSIS OF PROCTER & GAMBLE HEALTH

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Jun2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 PGHL is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF PROCTER & GAMBLE HEALTH

 
Valuation Score
[As on : Sep 30,2022 ]

Ratio Standalone
P/E
P/B
P/S
35.26
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 192.56 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

11.01
P/B Calculated based on Book Value of Rs 616.49 Cr
[Latest Year - Jun2022 - Standalone Results ]

6.09
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF PROCTER & GAMBLE HEALTH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
156%
106%
99%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF PROCTER & GAMBLE HEALTH



PROCTER & GAMBLE HEALTH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF PROCTER & GAMBLE HEALTH

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0
0
0.55
0.18
-
-
-
-
[Last Annual Data : Jun2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF PROCTER & GAMBLE HEALTH

Pledged Promoter Shares
0 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF PROCTER & GAMBLE HEALTH

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
10.48%
-14.15%
-15.74%
-19.49%
3.68%
21.86%
25.55%
21.54%
QtrlyTrend
2
Latest Qtr: Jun2022
Quarterly Result Analysis →


PROCTER & GAMBLE HEALTH related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 1.8% 1.4% -9.9%
S&P BSE 250 SMALLCAP -1% -0.6% -0.2%
S&P BSE 400 MIDSMALLCAP -1.2% -1.4% 0.8%
S&P BSE SMALL CAP -1.3% -0.7% 1.7%
S&P BSE MIDSMALLCAP -1.5% -1.4% 0.2%
NSE Indices1W1M1Y
NIFTY SMALLCAP250 -1.2% -0.9% -1.3%
NIFTY MID SMALL400 -1.3% -1.5% 1.9%
NIFTY500 MULTICAP 50:25:25 -1.4% -2.5% -1.2%
NIFTY 500 -1.5% -3.2% -2.4%

You may also like the below Video Courses


FAQ about PROCTER & GAMBLE HEALTH


Is PROCTER & GAMBLE HEALTH good for long term investment?

As on Sep 30,2022, the Fundamentals of PROCTER & GAMBLE HEALTH look Strong and hence it may be good for long term investment! See Financial Performance of PROCTER & GAMBLE HEALTH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is PROCTER & GAMBLE HEALTH UnderValued or OverValued?

As on Sep 30,2022, PROCTER & GAMBLE HEALTH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of PROCTER & GAMBLE HEALTH ?

As on Sep 30,2022, the Intrinsic Value of PROCTER & GAMBLE HEALTH is Rs. 1,986.23 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,599.75
Fair Value [Median EV / Sales Model] : Rs. 1,986.23
Fair Value [Median Price / Sales Model] : Rs. 2,054.25
Estimated Median Fair Value of PROCTER & GAMBLE HEALTH : Rs. 1,986.23

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is PROCTER & GAMBLE HEALTH trading at a Premium or Discount?

As on Sep 30,2022, PROCTER & GAMBLE HEALTH is trading at a Premium of 106% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].